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Q fever is a zoonotic disease caused by Coxiella
burnetii. Easy aerosol dissemination, strong envi-
ronmental persistence and high infectivity make
the bacterium a serious threat for humans and
animals. A rapid, sensitive and speciﬁc test for the
infectious agent is still a challenge in the ﬁeld.
C. burnetii expresses a spectrum of amphophilic
macromolecules on its surface. Among them, a
lipopolysaccharide (LPS) is of particular biologi-
cal, immunological and medical signiﬁcance [1].
Upon serial laboratory passages in yolk sacs of
embryonated hen eggs, C. burnetii undergoes a
virulent (phase I) to avirulent (phase II) variation.
This is accompanied by modiﬁcations in both
composition and structure of the LPS [1]. In
virulent phase I, the bacterium biosynthesises an
LPS that contains in the O-speciﬁc chain besides
some frequently occurring sugars two unusual
ones, virenose (Vir, 6-deoxy-3-C-methyl-D-gulose)
and dihydrohydroxystreptose [Strep, 3-C-(hy-
droxymethyl)-L-lyxose] [1]. Both sugars have not
been found in LPSs of other enterobacterial
species and are considered unique biomarkers of
C. burnetii. In previous work it was suggested that
Vir and Strep are located in terminal positions [1]
but recent ﬁndings show that Vir is also (1 ﬁ 4)-
linked [2]. The presence of unique biomarkers Vir
and Strep in the C. burnetii LPS and their favour-
able location in its O-speciﬁc chain provide an
excellent opportunity to generate monoclonal
antibodies (mAbs) against them that would
enable rapid, sensitive and speciﬁc detection of
the virulent form of the bacterium. In this paper,
we report on such a mAb that was highly speciﬁc
for Vir in the C. burnetii LPS.
The mAb (IgG2b subclass) was generated in
response to the Vir-rich O-polysaccharide fraction
of the C. burnetii isolate Nine Mile (NM) LPS
conjugated to tetanus toxoid. The following
C. burnetii isolates were tested with the mAb:
NM, Priscilla (Pr), S, 48, 1 ⁄ IIA, IXO, DER, L35, 27,
RAK8, L, Henzerling (He), Florian and LUGA (all
in phase I), NM, Pr, He (all in phase II), and a
laboratory variant of the NM isolate ‘Crazy’ (Cr,
intermediate to phases I and II). Their origin is
given [3,4] elsewhere. In addition, the phase I
LPSs from the isolates NM, Pr, S, 48, 1 ⁄ IIA, IXO,
He and LUGA; the phase II LPSs from NM, Pr
and He; and the LPS from Cr were tested, too.
Further, the cells of some selected members of the
families Rickettsiaceae (Rickettsia conorii, R. rickett-
sii, R. slovaca, R. typhi and R. sibirica), Piscirickett-
siaceae (Piscirickettsia salmonis), Chlamydiaceae
(Chlamydophila psittaci and C. abortus) and Entero-
bacteriaceae (Salmonella typhosa and Escherichia coli)
were examined for possible cross-reactivity with
the mAb. Likewise, LPSs from R. typhi, R. canada,
R. prowazekii, R. tsutsugamushi and S. typhosa were
submitted to analyses with the mAb in ELISA and
immunoblot assays. In immunoblots, cells and
LPSs were separated in 15% polyacrylamide gels,
transferred to PVDF membrane and examined
with the mAb diluted 1:5000 in blocking buffer at
20C for 1 h. After washing, the membrane was
incubated with anti-mouse IgG Ab conjugated
with horseradish peroxidase. The immunoreac-
tion was visualised with the light-emitting sub-
strate detection system. ELISA was carried out
with the same samples according to Slaba et al.
[5]. The mAb serially diluted from 1:1000
(220 ng ⁄well) was used as the primary Ab.
Immunoblot and ELISA studies have shown
that only Vir-containing C. burnetii cells and LPSs
were recognised with the mAb. In immunoblot,
variability in the immunoreactivity of phase I
LPSs and isolates was seen in both distribution of
the individual bands and their intensities in the
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most reactive region of about 14–36 kDa (Fig. 1).
In contrast, no binding was observed with the
phase II and Cr cells or their LPSs. Vir was absent
in all these samples. Likewise, no signals were
observed with the cells and LPSs from the
selected species of the families Rickettsiaceae,
Piscirickettsiaceae, Chlamydiaceae and Enterobacteri-
aceae.
The same results were obtained in ELISA.
Positive reactions of the cells and LPSs of
C. burnetii isolates in phase I with the mAb were
reﬂected in their corresponding titres. As in
immunoblot studies, no binding was observed
with the cells and LPSs of phase II isolates or the
Cr variant, nor with other bacterial species men-
tioned above.
In conclusion, the results have shown that
immunoblotting and ELISA with the newly gen-
erated mAb could be useful tools for both sensi-
tive and speciﬁc detection of the virulent form of
C. burnetii and for differentiation of the individual
isolates.
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Fig. 1. Representative immunoblot of the LPSs of NM (1),
Pr (2), S (3), 48 (4), 1 ⁄ IIA (5), IXO (6) all in phase I, Cr (7)
and S. typhosa (8), the whole cell lysates of NM (9) and Pr
(11) in phase I, NM (10) and Pr (12) in phase II, and Cr (13)
with the anti-Vir mAb. For abbreviations, see text.
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